The SARS-CoV-2 Spike variant D614G favors an open conformational state
Open accessPublished version of a preprint
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Symmetrization of contacts in D614G SARS-CoV-2 Spike favors greater probability of infection-capable conformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Fig. 7 RBD is more exposed in the one-up conformation. (A) Surface representation of the all-down Spike complex. Colors ranging between red, white, and blue represent values for the GEF. GEF describes relative exposure and coverage of protein surfaces. (B) Surface representation of the one-up Spike. Colors ranging between cyan, white, and magenta indicate GEF differences between the closed and open structures. The RBD in the up orientation is indicated by the dotted circle, where the originally buried (magenta) region around 458 to 478 is now exposed. (C and D) Top view of the Spike protein apex in (C) all-down and (D) one-up conformations. Protein surface is shown in gray. Glycan ensembles covering the protein surface are represented by point densities. Fucosylated 2 and 3 antennae complex (FA2 and FA3) glycans and oligomannose (OM) glycans are depicted in dark red, orange, and green. Binding site region, which includes RBM (residues 438 to 506) and C105 antibody binding residues (i.e., 403, 405, 406, 408, 409, 415 to 417, 420, 421, 449, 453, 455 to 460, 473 to 477, 486, 487, 489, 493 to 496, 498, and 500 to 505), is colored yellow. These binding site residues are more exposed in the one-up conformation, compared to the all-down case. (E) Representative configuration describing S309 Fab binding to an up-RBD in G-form that shows no rotation toward NTD of the neighboring protomer on the right (~0° rolling angle) (top view of the Spike is shown). This structure shows that the Fab domain does not sterically clash with the Spike protein. (F) Representative configuration showing S309 Fab binding to an up-RBD in D-form where the RBD is rotated toward the NTD of the neighboring protomer on the right [rolling angle is <−10°; same view as in (E) is shown]. The Fab domain starts to sterically clash with the Spike protein NTD of the neighboring protomer. See Supplementary Materials and Methods and fig. S7 for details on RBD rotations.](https://figures.cochat.ai/paper-figures/aa66899fbf54404c86024638352dc87b/the-sars-cov-2-spike-variant-d614g-favors-an-open-conformational-state-figure-7.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the G614 form, due to the relaxation of tensile hydrogen bonds, a higher population of infection capable of open configurations results in higher chances of binding events with the host receptor ACE-2, thereby increasing the overall infectivity.”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it is well established that mutation D614G increases viral transmission and promotes ACE2 engagement”
From The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic (2022) · cites this paper as Mansbach et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“in the G614 form, due to the relaxation of tensile hydrogen bonds, a higher population of infection capable of open configurations results in higher chances of binding events with the host receptor ACE-2, thereby increasing the overall infectivity.”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Structural analysis by atomic simulations and molecular-level studies showed asymmetric inter-promoter interactions between S1 and S2 subunits in the open state during the D614 form.”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Enhanced exposure of RBD in the open configuration is also predicted to be a reason for higher sensitivity toward neutralization [27].”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VMD: visual molecular dynamics
Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952 · cited 4×
“W. Humphrey, A. Dalke, K. Schulten, VMD: Visual molecular dynamics.”
InfluentialUCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Comparison of simple potential functions for simulating liquid water
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983) · The Journal of Chemical Physics · doi:10.1063/1.445869 · Cited by 41,298 · cited 1×
“3 software packages (30, 31), using the CHARMM36m (32) force field and TIP3P water model (33).”
Matplotlib: a 2D graphics environment
Hunter, J. D. (2007) · Computing in Science & Engineering · doi:10.1109/mcse.2007.55 · Cited by 39,249 · cited 1×
“A careful analysis 66 of RBD exposure, including the role of the highly-flexible glycans, showed that both the ACE2 67 binding site and critical neutralizing antibody epitopes in the RBD are more accessible in the one68 up state (1), (7), (8).”
Molecular dynamics with coupling to an external bath
Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984) · The Journal of Chemical Physics · doi:10.1063/1.448118 · Cited by 30,700
Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015) · SoftwareX · doi:10.1016/j.softx.2015.06.001 · Cited by 27,190 · cited 1×
“3 software packages (30, 31), using the CHARMM36m (32) force field and TIP3P water model (33).”
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581 · cited 9×
“model based on DOPE and Procheck scores (5), (6).”
InfluentialA smooth particle mesh Ewald method
Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995) · The Journal of Chemical Physics · doi:10.1063/1.470117 · Cited by 22,514 · cited 1×
“12 nm, an interpolation order of 4, and a tolerance of 1 × 10−5 (37).”
GROMACS: Fast, flexible, and free
Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20291 · Cited by 19,182
LINCS: A linear constraint solver for molecular simulations
Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h · Cited by 18,260
Research works printed but not linked: 1
- 10.1021/bi962514 · doi:10.1021/bi962514
Cited by
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020) · Science · doi:10.1126/science.abe8499 · Cited by 900
Hoffmann, M., Krüger, N., Schulz, S., Cossmann, A., Rocha, C., Kempf, A., Nehlmeier, I., Graichen, L., Moldenhauer, A.-S., Winkler, M. S., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.032 · Cited by 889
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors
Meyerowitz, E. A., Richterman, A., Gandhi, R. T., & Sax, P. E. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5008 · Cited by 747
Duan, L., Zheng, Q., Zhang, H., Niu, Y., Lou, Y., & Wang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576622 · Cited by 408
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Westendorf, K., Žentelis, S., Wang, L., Foster, D., Vaillancourt, P., Wiggin, M., Lovett, E., van der Lee, R., Hendle, J., Pustilnik, A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110812 · Cited by 414
The coronavirus is mutating — does it matter?
Callaway, E. (2020) · Nature · doi:10.1038/d41586-020-02544-6 · Cited by 340
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Weissman, D., Alameh, M.-G., de Silva, T., Collini, P., Hornsby, H., Brown, R., LaBranche, C. C., Edwards, R. J., Sutherland, L., Santra, S., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.012 · Cited by 324
Self-citationShah, M., & Woo, H. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.830527 · Cited by 255
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Thakur, V., Bhola, S., Thakur, P., Patel, S. K. S., Kulshrestha, S., Ratho, R. K., & Kumar, P. (2022) · Infection · doi:10.1007/s15010-021-01734-2 · Cited by 195
Peng, R., Wu, L.-A., Wang, Q., Qi, J., & Gao, G. F. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.06.001 · Cited by 159
Chakraborty, C., Sharma, A. R., Bhattacharya, M., & Lee, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801522 · Cited by 161
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Singh, J., Pandit, P., McArthur, A. G., Banerjee, A., & Mossman, K. L. (2021) · Virology Journal · doi:10.1186/s12985-021-01633-w · Cited by 170
Groves, D. C., Rowland‐Jones, S., & Angyal, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.109 · Cited by 136
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsPreprint
Westendorf, K., Žentelis, S., Wang, L., Foster, D., Vaillancourt, P., Wiggin, M., Lovett, E., van der Lee, R., Hendle, J., Pustilnik, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.30.442182 · Cited by 131
Chakraborty, C., Bhattacharya, M., & Sharma, A. R. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2270 · Cited by 111
“Through the in vitro experiments, researchers observed that G‐form is highly infectious and is related to higher viral loads in the upper part of the airway in the respiratory tract.(72) Similarly, this S‐glycoprotein mutation is associated with the transmissibility of the new variant.”
InfluentialHIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens
Fischer, W. M., Giorgi, E. E., Chakraborty, S., Nguyen, K., Bhattacharya, T., Theiler, J. P., Goloboff, P. A., Yoon, H., Abfalterer, W., Foley, B. T., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.012 · Cited by 114
Self-citationTeruel, N., Mailhot, O., & Najmanovich, R. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009286 · Cited by 105
(2022) · doi:10.1038/s41564-022-01092-1 · Cited by 98
Functional importance of the D614G mutation in the SARS-CoV-2 spike protein
Jackson, C. B., Zhang, L., Farzan, M., & Choe, H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.11.026 · Cited by 97
Distant residues modulate conformational opening in SARS-CoV-2 spike protein
Ray, D., Le, L., & Andricioaei, I. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100943118 · Cited by 94
Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
Calvaresi, V., Wrobel, A. G., Toporowska, J., Hammerschmid, D., Doores, K. J., Bradshaw, R. T., Parsons, R. B., Benton, D. J., Roustan, C., Reading, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36745-0 · Cited by 84
Shah, M., Ahmad, B., Choi, S., & Woo, H. G. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.002 · Cited by 79
Butowt, R., Bilińska, K., & von Bartheld, C. S. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00596 · Cited by 78
Ilmjärv, S., Abdul, F., Acosta‐Gutiérrez, S., Estarellas, C., Galdadas, I., Casimir, M., Alessandrini, M., Gervasio, F. L., & Krause, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-91662-w · Cited by 74
Gan, H. H., Twaddle, A., Marchand, B., & Gunsalus, K. C. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167051 · Cited by 78
Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants
Koehler, M., Ray, A., Moreira, R. A., Juniku, B., Poma, A. B., & Alsteens, D. (2021) · Nature Communications · doi:10.1038/s41467-021-27325-1 · Cited by 75
Multifaceted Computational Modeling in Glycoscience
Pérez, S., & Makshakova, O. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00060 · Cited by 78
SARS-CoV-2 Variants and Clinical Outcomes: A Systematic Review
Mendiola-Pastrana, I. R., López‐Ortiz, E., de la Loza-Zamora, J. G. R., González, J., Gómez‐García, A., & López-Ortiz, G. (2022) · Life · doi:10.3390/life12020170 · Cited by 78
Pang, Y. T., Acharya, A., Lynch, D. L., Pavlova, À., & Gumbart, J. C. (2022) · Communications Biology · doi:10.1038/s42003-022-04138-6 · Cited by 69
von Bartheld, C. S., Hagen, M. M., & Butowt, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00542 · Cited by 61
Zhang, L., Cui, Z., Li, Q., Wang, B., Yu, Y., Wu, J., Nie, J., Ding, R., Wang, H., Zhang, Y., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02728-4 · Cited by 62
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
Maisonnasse, P., Aldon, Y., Marc, A., Marlin, R., Dereuddre‐Bosquet, N., Kuzmina, N. A., Freyn, A. W., Snitselaar, J. L., Gonçalves, A., Caniels, T. G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26354-0 · Cited by 61
Self-citationBanach, B. B., Cerutti, G., Fahad, A. S., Shen, C.-H., Oliveira De Souza, M., Katsamba, P. S., Tsybovsky, Y., Wang, P., Nair, M. S., Huang, Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109771 · Cited by 60
Verkhivker, G. M., & Paola, L. D. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c10637 · Cited by 63
Verkhivker, G. M., & Paola, L. D. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c00395 · Cited by 56
Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants
Monteil, V., Eaton, B., Postnikova, E. N., Murphy, M. J., Braunsfeld, B., Crozier, I., Kricek, F., Niederhöfer, J., Schwarzböck, A., Breid, H., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202115230 · Cited by 54
D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity
Bhattacharya, M., Chatterjee, S., Sharma, A. R., Agoramoorthy, G., & Chakraborty, C. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11676-2 · Cited by 56
The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
Kim, Y. J., Jang, U. S., Soh, S. M., Lee, J., & Lee, H.-R. (2021) · Viruses · doi:10.3390/v13040633 · Cited by 48
The Development of SARS-CoV-2 Variants: The Gene Makes the Disease
Pérez-Gómez, R. (2021) · Journal of Developmental Biology · doi:10.3390/jdb9040058 · Cited by 47
Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core
Pak, A. J., Yu, A., Ke, Z., Briggs, J. A. G., & Voth, G. A. (2022) · Nature Communications · doi:10.1038/s41467-022-28654-5 · Cited by 50
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Hoteit, R., & Yassine, H. M. (2022) · Vaccines · doi:10.3390/vaccines10060919 · Cited by 51
Immunity to SARS-CoV-2: Lessons Learned
FERGIE, J. E., & Srivastava, A. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654165 · Cited by 50
Waman, V. P., Sen, N., Varadi, M., Daina, A., Wodak, S. J., Zoete, V., Velankar, S., & Orengo, C. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa362 · Cited by 46
Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview
Mehra, R., & Kepp, K. P. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00433 · Cited by 45
Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency
Alaofi, A. L., & Shahid, M. (2021) · Biomolecules · doi:10.3390/biom11091273 · Cited by 44
Schuurs, Z. P., Hammond, E., Elli, S., Rudd, T. R., Mycroft‐West, C. J., de Lima, M. A., Skidmore, M. A., Karlsson, R. T. G., Chen, Y., Bagdonaite, I., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.002 · Cited by 45
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay
Elizondo, V., Harkins, G. W., Mabvakure, B. M., Smidt, S., Zappile, P., Marier, C., Maurano, M. T., Perez, V., Mazza, N., Beloso, C., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1863747 · Cited by 48
Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H
Zeng, C., Evans, J. P., Faraone, J. N., Qu, P., Zheng, Y.-M., Saif, L. J., Oltz, E. M., Lozanski, G., Gumina, R. J., & Liu, S. (2021) · mBio · doi:10.1128/mbio.02510-21 · Cited by 42
“1b and c), likely because the D614G mutation stabilizes the “open” (RBD-exposed) spike conformation (21).”
Verkhivker, G. M., Agajanian, S., Öztaş, D. Y., & Gupta, G. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00372 · Cited by 40
Chakraborty, C., Saha, A., Sharma, A. R., Bhattacharya, M., Lee, S., & Agoramoorthy, G. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.07.011 · Cited by 42
“The spike protein consists of three protomers, and when they interact with the ACE2 receptor, it promotes the entry of the virus into a host cell.(4) Thus, the spike protein has become a specific target for scientists to formulate therapeutic approaches, and therefore, the molecular structure of the spike protein has…”
Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
Huang, Y., Sun, H., Yu, H. J., Li, S., Zheng, Q., & Xia, N. (2020) · Antibody Therapeutics · doi:10.1093/abt/tbaa028 · Cited by 45
Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2
Nguyen, K., Chakraborty, S., Mansbach, R. A., Korber, B., & Gnanakaran, S. (2021) · Viruses · doi:10.3390/v13050927 · Cited by 41
Self-citationMolecular dynamics of the viral life cycle: progress and prospects
Jones, P. E., Pérez-Segura, C., Bryer, A. J., Perilla, J. R., & Hadden‐Perilla, J. A. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.08.003 · Cited by 38
Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein
Tan, Z. W., Tee, W.-V., Samsudin, F., Guarnera, E., Bond, P. J., & Berezovsky, I. N. (2022) · Structure · doi:10.1016/j.str.2021.12.011 · Cited by 38
Molecular adaptations during viral epidemics
Rochman, N. D., Wolf, Y. I., & Koonin, E. V. (2022) · EMBO Reports · doi:10.15252/embr.202255393 · Cited by 43
“A glycine in position 614 stabilizes the trimer and introduces a kinetic barrier decreasing the rate of conversion between up and down conformations (Mansbach et al , 2021).”
Cardozo, T. J., & Veazey, R. S. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13795 · Cited by 37
Negi, S. S., Schein, C. H., & Braun, W. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-04950-4 · Cited by 36
Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil
Franceschi, V. B., Caldana, G. D., Mayer, A. D. M., Cybis, G. B., Neves, C. A. M., Ferrareze, P. A. G., Demoliner, M., de Almeida, P. R., Gularte, J. S., Hansen, A. W., et al. (2021) · BMC Genomics · doi:10.1186/s12864-021-07708-w · Cited by 38
Çelik, İ., Khan, A., Dwivany, F. M., Fatimawali, F., Wei, D., & Tallei, T. E. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10392-x · Cited by 33
de Souza, A. S., Amorim, V. M. D. F., Guardia, G. D. A., dos Santos, F. F., Ulrich, H., Galante, P. A. F., de Souza, R. F., & Guzzo, C. R. (2022) · Viruses · doi:10.3390/v14040827 · Cited by 30
Guo, C., Tsai, S. J., Ai, Y., Li, M., Pekosz, A. S., Cox, A., Atai, N. A., & Gould, S. J. (2022) · Science Advances · doi:10.1126/sciadv.ade5085 · Cited by 31
The virological impacts of SARS-CoV-2 D614G mutation
Wang, C., Zheng, Y. Y., Niu, Z., Jiang, X., & Sun, Q. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab045 · Cited by 29
Proteases and variants: context matters for SARS-CoV-2 entry assays
Stevens, C. S., Oguntuyo, K. Y., & Lee, B. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.07.004 · Cited by 28
Barrett, C. T., Neal, H. E., Edmonds, K. L., Moncman, C. L., Thompson, R., Branttie, J. M., Boggs, K. B., Wu, C., Leung, D. W., & Dutch, R. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100902 · Cited by 32
Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex
Ahmed, W. S., Philip, A. M., & Biswas, K. H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.846996 · Cited by 31
Shen, Y., Eades, W. C., Liu, W., & Yan, B. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000918 · Cited by 27
Fang, L., Xu, J., Zhao, Y., Fan, J., Shen, J., Liu, W., & Cao, G. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1228128 · Cited by 27
Zhao, S., Zhang, H., Yang, X., Zhang, H., Chen, Y., Zhan, Y., Zhang, X., Jiang, R.-D., Liu, M., Liu, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25153-x · Cited by 26
Li, R., Mor, M., Ma, B., Clark, A. E., Alter, J., Werbner, M., Lee, J. C., Leibel, S. L., Carlin, A. F., Dessau, M., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03739-5 · Cited by 27
Peptide Antidotes to SARS-CoV-2 (COVID-19)Preprint
Watson, A., Ferreira, L. M. R., Hwang, P. K., Xu, J., & Stroud, R. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.06.238915 · Cited by 24
Structural effects of spike protein D614G mutation in SARS-CoV-2
Dokainish, H., & Sugita, Y. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.11.025 · Cited by 23
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
Damavandi, A. R., Dowran, R., Sharif, S. A., Kashanchi, F., & Jafari, R. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00729-6 · Cited by 23
Pre‐exascale HPC approaches for molecular dynamics simulations. Covid‐19 research: A use case
Wieczór, M., Genna, V., Aranda, J., Badia, R. M., Gelpí, J. L., Gapsys, V., de Groot, B. L., Lindahl, E. R., Municoy, M., & Orozco, M. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1622 · Cited by 21
Kircheis, R., & Planz, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115966 · Cited by 22
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
Trinité, B., Pradenas, E., Marfil, S., Rovirosa, C., Urrea, V., Tarrés-Freixas, F., Ortiz, R., Rodon, J., Vergara‐Alert, J., Segalés, J., et al. (2021) · Viruses · doi:10.3390/v13061135 · Cited by 20
Fatihi, S., Rathore, S., Pathak, A. K., Gahlot, D., Mukerji, M., Jatana, N., & Thukral, L. (2021) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2021.11.002 · Cited by 23
“In another study, a total of 20 μ s MD simulation trajectory of both wild type and D614G mutant provided mechanistic details of the increased occupancy of open state in G614 form (Mansbach et al., 2021).”
Application of omics technology to combat the COVID‐19 pandemic
Yang, J., Yan, Y., & Zhong, W. (2021) · MedComm · doi:10.1002/mco2.90 · Cited by 21
Ghosh, D., Dastidar, D. G., Roy, K., Ghosh, A., Mukhopadhyay, D., Sikdar, N., Biswas, N. K., Chakrabarti, G., & Das, A. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-09845-y · Cited by 22
GROMACS Stochastic Dynamics and BAOAB Are Equivalent Configurational Sampling Algorithms
Kieninger, S., & Keller, B. G. (2022) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.2c00585 · Cited by 19
Wang, D., Zhou, B., Keppel, T. R., Solano, M. I., Baudys, J., Goldstein, J. M., Finn, M. G., Fan, X., Chapman, A. P., Bundy, J. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-02904-w · Cited by 19
Verkhivker, G. M., Agajanian, S., Kassab, R., & Krishnan, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911542 · Cited by 19
Lee, H., Wang, W., Chauhan, N., Xiong, Y., Magazine, N., Valdescruz, O., Kim, D. Y., Qiu, T., Huang, W., Wang, X., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115228 · Cited by 18
Yan, D., & Yan, B. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12889 · Cited by 19
Verkhivker, G. M., Agajanian, S., Kassab, R., & Krishnan, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084376 · Cited by 19
SARS-CoV-2 Variants: Mutations and Effective Changes
Park, G., & Hwang, B. H. (2021) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-021-0327-3 · Cited by 17
Verkhivker, G. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062928 · Cited by 17
DiIorio, M. C., & Kulczyk, A. (2023) · Micromachines · doi:10.3390/mi14091674 · Cited by 19
Guo, D., Duan, H., Cheng, Y., Wang, Y., Hu, J., & Shi, H. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00074-3 · Cited by 18
Dumache, R., Enache, A., Macasoi, I. G., Dehelean, C. A., Dumitrascu, V. C., Mihailescu, A., Popescu, R., Vlad, M., Vlad, C. S., & Mureşan, C. O. (2022) · Pathogens · doi:10.3390/pathogens11050516 · Cited by 18
Granata, V., Fusco, R., Villanacci, A., Magliocchetti, S., Urraro, F., Tetaj, N., Marchioni, L., Albarello, F., Campioni, P., Cristofaro, M., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060955 · Cited by 18
Bader, W., Delerce, J., Aherfi, S., Scola, B. L., & Colson, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415658 · Cited by 17
Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1
Qiao, S., & Wang, X. (2024) · Journal of Virology · doi:10.1128/jvi.00342-24 · Cited by 17
Verkhivker, G. M., Agajanian, S., Kassab, R., & Krishnan, K. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00124 · Cited by 18
SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation
Fayad, N., Habib, W. A., Kandeil, A., El‐Shesheny, R., Kamel, M. N., Mourad, Y., Mokhbat, J., Kayali, G., Goldstein, J., & Abdallah, J. (2021) · Biology · doi:10.3390/biology10060531 · Cited by 15
Shah, M., Moon, S. U., Kim, J. H., Thao, T. T., & Woo, H. G. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.04.030 · Cited by 17
Lee, M., Major, M. E., & Hong, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043774 · Cited by 17
Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation
Nguyen, H. V., Nguyen, H. L., Lan, P. D., Thai, N. Q., Sikora, M., & Li, M. S. (2023) · Chemical Society Reviews · doi:10.1039/d1cs01170g · Cited by 16
Single-Molecule Investigation of the Binding Interface Stability of SARS-CoV-2 Variants with ACE2
Ray, A., Thu, T. T. M., Natividade, R. D. S., Moreira, R. A., Simpson, J. D., Mohammed, D., Koehler, M., Petitjean, S. J. L., Zhang, Q., Bureau, F., et al. (2024) · ACS Nanoscience Au · doi:10.1021/acsnanoscienceau.3c00060 · Cited by 14
Peptides and peptidomimetics as therapeutic agents for Covid‐19
Dahal, A., Sonju, J. J., Kousoulas, K. G., & Jois, S. D. S. (2021) · Peptide Science · doi:10.1002/pep2.24245 · Cited by 17
Moreno, N., Moreno-Chaparro, D., Usabiaga, F. B., & Ellero, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-14884-6 · Cited by 16
Metadata
- Authors
- Mansbach, R. A., Chakraborty, S., Nguyen, K., Montefiori, D. C., Korber, B., & Gnanakaran, S.
- Affiliations
- Los Alamos National Laboratory (US)
- Duke University (US)
- Corresponding author
- Gnanakaran, S.
- ORCID
- Venue
- Science Advances
- Published
- 2021-04-16
- Volume
- 7
- Issue
- 16
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8051874
- OpenAlex
- W3153528761
- Cited by
- 206
- References
- 59
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 26 · 2022: 64 · 2021: 68
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy (89233218CNA000001)
- NIH Office of the Director (P50GM085273)
- Los Alamos National Laboratory (Director’s Postdoctoral Fellowship, Center of Nonlinear Studies Postdoctoral Program, 20200706ER)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- SARS-CoV-2, spike protein, D614G mutation, protein conformational dynamics, receptor binding domain, ACE2 binding, viral infectivity, neutralizing antibodies, vaccine design, COVID-19 pandemic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.